Predictors of intrahospitalary mortality in the upper gastrointestinal variceal bleeding due to chronic liver disease treated endoscopically;Predictores de mortalidad hospitalaria en la hemorragia digestiva alta variceal por hepatopatía crónica tratada endoscópicamente

Acta Gastroenterologica Latinoamericana

Volumn 38, Issue 1, 2008, Pages 43-50

  Berreta, Julio ^a   Kociak, Daniel ^a   Corti, Rodolfo ^a   Morales, Guillermo ^a   Ortiz, Mercedes ^a   Laplacette, María ^a   Bellido, Fernando ^a   Romero, Gustavo ^a   Salgado, Pablo ^a   Tumilasci, Omar ^b  

^a HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Chronic liver disease; Hepatic cirrhosis; Mortality predictors; Variceal bleeding

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; EPIDEMIOLOGY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; LIVER DISEASE; MALE; MIDDLE AGED; MORTALITY; TREATMENT FAILURE;

ADULT; AGED; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 40949104284     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652-659.
2. Clark AW, MacDougall BR, Westaby D, Mitchell KJ, Silk DB, Strunin L, Dawson JL, Williams R. Prospective controlled trial of injection sclerotherapy in patients with cirrhosis and recent variceal hemorrhage. Lancet 1980;2:552-554.
3. Stiegmann GV, Goff JS. Endoscopic esophageal varix ligation: preliminary clinical experience. Gastrointest Endosc 1988;34:113-117.
4. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, Reveille RM, Sun JH, Lowenstein SR. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;4:1527-1532.
5. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, Chiang HT. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997;25:1101-1104.
6. Sung JJ, Chung SC, Lai CW, Chan FK, Leung JW, Yung MY, Kassianides C, Li AK. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993;11:637-641.
7. Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 2001;120:946-954.
8. Freeman JG, Cobden I, Record CO. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989;11:58-60.
9. Soderlund C, Magnusson I, Torngren S, Lundell L. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990;25:622-630.
10. Valenzuela JE, Schubert T, Fogel MR, Strong RM, Levine J, Mills PR, Fabry TL, Taylor LW, Conn HO, Posillico JT. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology. 1989;10:958-961.
11. Gotzsche PC, Gjorup I, Bonnen H, Brahe NE, Becker U, Burcharth F. Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis. BMJ 1995;310:1495-1498.
12. Gotzsche PC, Gjorup IE, Bonnen H, Brahe NE, Becker PU, Burcharth F. Randomized trial and meta-analysis of somatostatin versus placebo in bleeding esophageal varices. Ugeskr Laeger 1996;22:2393-2396.
13. Walker S, Kreichgauer HP, Bode JC. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices - final report of a placebo-controlled, double-blind study. Z Gastroenterol 1996;34:692-698.
14. Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003;17:53-64.
15. Avgerinos A, Armonis A, Raptis S. Somatostatin or octreotide versus endoscopic sclerotherapy in acute variceal haemorrhage: a meta-analysis study. J Hepatol 1995;22:247-248.
16. Planas R, Quer JC, Boix J, Canet J, Armengol M, Cabre E, Pintanel T, Humbert P, Oller B, Broggi MA, et al. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994;20:370-375.
17. Shields R, Jenkins SA, Baxter JN, Kingsnorth AN, Ellenbogen S, Makin CA, Gilmore I, Morris AI, Ashby D, West CR. A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 1992;16:128-1237.
18. Bildozola M, Kravetz D, Argonz J, Romero G, Suarez A, Jmelnitzky A, Fainberg M, Fassio E, Berreta J, Romero G, Landeira G, Martinez H, Bosco A, Guevara M, Valero J, Chopita N, Berenstein G, Terg R. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand J Gastroenterol 2000;35:419-425.
19. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003;124:1277-1291.
20. Sung JJ, Chung SC, Yung MY, Lai CW, Lau JY, Lee YT, Leung VK, Li MK, Li AK. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346:1666-1669.
21. Villanueva C, Ortiz J, Sabat M, Gallego A, Torras X, Soriano G, Sainz S, Boadas J, Cusso X, Guarner C, Balanzo J. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 1999;30:384-389.
22. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, Hochain P, Larricq J, Gourlaouen A, Ribard D, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;31:555-560.
23. Shah HA, Mumtaz K, Jafri W, Abid S, Hamid S, Ahmad A, Abbas Z. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage. J Ayub Med Coll Abbottabad 2005;17:10-14.
24. Freitas DS, Sofia C, Pontes JM, Gregorio C, Cabral JP, Andrade P, Rosa A, Camacho E, Ferreira M, Portela F, Romaozinho JM, Tome L, Gouveia H, Leitao M, Pimenta I, Donato A. Octreotide in acute bleeding esophageal varices: a prospective randomized study. Hepatogastroenterology 2000;47:1310-1314.
25. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1997;22:1495-1499.
26. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D; French Club for the Study of Portal Hypertension. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;4:23-28.
27. Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994;20:34-38.
28. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999;29:1655-1661.
29. Soares-Weiser K, Brezis M, Tur-Kaspa R, Paul M, Yahav J, Leibovici L. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 2003;38:193-200.
30. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-852.
31. Japanese Research Society of Portal Hypertension. The general rules for recording endoscopic findings of esophageal varices. Jpn J Surg 1980;10:84-87.
32. Knauss W, Draper E, Wagner DP, Zimmerman J. APACHE II: a severity of disease Classification System. Crit. Care Med 1985;13:818-829.
33. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG,ed. The liver and Portal hypertension. WB Saunders and Co Philadelphia 1964.
34. Pugh RW, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1983;60:646-649.
35. Sengstaken RW, Blakemore AH. Balloon tamponage for control of hemorrhage from esophageal varices. Ann Surg 1950;131:781-789.
36. Thomopoulos K, Theocharis G, Mimidis K, Lampropoulou-Karatza C, Alexandridis E, Nikolopoulou V. Improved survival of patients presenting with acute variceal bleeding Prognostic indicators of short and long-term mortality. Dig Liver Dis 2006;38:899-904.
37. Dy SM, Cromwell DM, Thuluvath PJ, Bass EB. Hospital experience and outcomes for esophageal variceal bleeding. Int J Qual Health Care 2003;15:139-146.
38. Feretis C, Dimopoulos C, Benakis P, Kalliakmanis B, Apostolidis N. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy 1995;27:355-357.
39. Kind R, Guglielmi A, Rodella L, Lombardo F, Catalano F, Ruzzenente A, Borzellino G, Girlanda R, Leopardi F, Prattico F, Cordiano C. Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy 2000;32:512-519.
40. Hartigan PM, Gebhard RL, Gregory PB. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Veterans Affairs Cooperative Variceal Sclerotherapy Group. Gastrointest Endosc 1997;46:1-7.
41. Kassa E. Endoscopic injection sclerotherapy of bleeding oesophageal varices: a retrospective analysis. Crit Care Med 1992;20:1555-1563.
42. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitamaran S, Shen J. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653-659.
43. Lee H, Hawker FH, Selby W, McWilliam DB, Herkes RG. Intensive care treatment of patients with bleeding esophageal varices: results, predictors of mortality, and predictors of the adult respiratory distress syndrome. Crit Care Med 1992;20:1555-1563.
44. Piqueras B, Banares R, Rincon D, Matilla A, Casado M, Salcedo M, Alonso S, Vaquero J. Predictive factors of the mortality of digestive hemorrhage caused by esophageal varices in elderly patients. Gastroenterol Hepatol 2001;24:51-55.
45. Lata J, Husova L, Jurankova J, Senkyrik M, Dite P, Dastych M Jr, Dastych M, Kroupa R. Factors participating in the development and mortality of variceal bleeding in portal hypertension-possible effects of the kidney damage and malnutrition. Hepatogastroenterology 2006;53:420-425.